IDE892
IDE892-001
Phase 1 small_molecule active
Quick answer
IDE892 for NSCLC Adenocarcinoma is a Phase 1 program (small_molecule) at IDEAYA Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IDEAYA Biosciences
- Indication
- NSCLC Adenocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active